In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.
Cheminformatics refers to the use of physical chemistry theory with computer and information science techniques—so called "in silico" techniques—in application to a range of descriptive and prescriptive problems in the field of chemistry, including in its applications to biology and related molecular fields. Such in silico techniques are used, for example, by pharmaceutical companies and in academic settings to aid and inform the process of drug discovery, for instance in the design of well-defined combinatorial libraries of synthetic compounds, or to assist in structure-based drug design. The methods can also be used in chemical and allied industries, and such fields as environmental science and pharmacology, where chemical processes are involved or studied.
The Journal of Medicinal Chemistry is a biweekly peer-reviewed medical journal covering research in medicinal chemistry. It is published by the American Chemical Society. It was established in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry and obtained its current name in 1963. Philip S. Portoghese served as editor-in-chief from 1972 to 2011. In 2012, Gunda Georg and Shaomeng Wang succeeded Portoghese. In 2021, Craig W. Lindsley became editor-in-chief. According to the Journal Citation Reports, the journal has a 2021 impact factor of 8.039, ranking it 1st out of 61 journals in the category "Chemistry, Medicinal".
Tetrahedron Letters is a weekly international journal for rapid publication of full original research papers in the field of organic chemistry. According to the Journal Citation Reports, the journal has a 2020 impact factor of 2.415.
Organic & Biomolecular Chemistry is a weekly peer-reviewed scientific journal covering all aspects of organic chemistry, including organic aspects of chemical biology, medicinal chemistry, natural product chemistry, supramolecular chemistry, macromolecular chemistry, theoretical chemistry, and catalysis. It is published by the Royal Society of Chemistry. Its predecessor journals were Perkin Transactions I and Perkin Transactions II. The Executive Editor is Richard Kelly.
The Journal of Labelled Compounds and Radiopharmaceuticals is a peer-reviewed scientific journal that was established in 1965. It is published in fourteen issues per year by John Wiley & Sons on behalf of the International Isotope Society and covers all aspects of research and development leading to and resulting in labelled compound preparation. The current editor-in-chiefs are R F Dannals and V Derdau.
Phytotherapy Research is a monthly peer-reviewed scientific journal publishing original research papers, short communications, reviews, and letters on medicinal plant research. Key areas of interest are pharmacology, toxicology, and the clinical applications of herbs and natural products in medicine, from case histories to full clinical trials, including studies of herb-drug interactions and other aspects of the safety of herbal medicines. Papers concerned with the effects of common food ingredients and standardised plant extracts, including commercial products, are particularly relevant, as are mechanistic studies on isolated natural products.
Phytochemistry is a peer-reviewed scientific journal covering pure and applied plant chemistry, plant biochemistry and molecular biology. It is published by Elsevier and is an official publication for the Phytochemical Society of Europe, the Phytochemical Society of North America, and the Phytochemical Society of Asia.
Planta Medica is a peer-reviewed journal published by Thieme Medical Publishers and covers medicinal plants and bioactive natural products of natural origin. Planta Medica is the official journal of the Society for Medicinal Plant and Natural Product Research (GA). According to the Journal Citation Reports, the journal's 2016 impact factor is 2.342. Planta Medica is a Q1 journal in integrative and complementary medicine, and a Q2 journal in plant sciences.
MedChemComm is a peer-reviewed scientific journal publishing original (primary) research and review articles on all aspects of medicinal chemistry, including drug discovery, pharmacology and pharmaceutical chemistry. Until December 2019, it was published monthly by the Royal Society of Chemistry in partnership with the European Federation for Medicinal Chemistry, of which it was the official journal. Authors can elect to have accepted articles published as open access. According to the Journal Citation Reports, the journal has a 2014 impact factor of 2.495, ranking it 27th out of 59 journals in the category "Chemistry, Medicinal" and 163 out of 289 journals in the category "Biochemistry & Molecular Biology".
Current Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang. The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry. Current Cancer Drug Targets publishes original research reports, review papers, and rapid communications ("letters").
Current Medicinal Chemistry is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Atta-ur-Rahman, FRS. The journal covers developments in medicinal chemistry and rational drug design and publishes original research reports and review papers.
Current Topics in Medicinal Chemistry is a biweekly peer-reviewed medical journal published by Bentham Science Publishers. It includes review articles on all aspects of medicinal chemistry, including drug design. The current editor-in-chief is Jia Zhou.
Mini-Reviews in Medicinal Chemistry is a monthly peer-reviewed medical journal covering all aspects of medicinal chemistry. It is published by Bentham Science Publishers and the editors-in-chief are Atta-ur-Rahman, M. Iqbal Choudhary, and George Perry.
Harkishan Singh was Professor Emeritus at the Panjab University. He was a well recognized pharmaceutical academic, medicinal chemistry researcher and science historian. He had more than half a century experience in his respective fields to his credit. He worked at the Banaras Hindu University, University of Saugar, and the Panjab University in India, and abroad at the University of Maryland, University of Mississippi and the University of London.
Kuo-Chen Chou was a Chinese-American biophysicist and bioinformatician who founded the Gordon Life Science Institute, a non-profit research organization in Boston, Massachusetts. Among other contributions, he developed pseudo amino acid composition (PseAAC), used in computational biology for proteomics analysis and pseudo K-tuple nucleotide composition (PseKNC) for genome analysis. He is the father of James Chou.
Anti-Cancer Agents in Medicinal Chemistry is a peer-reviewed academic journal covering the disciplines of medicinal chemistry and drug design relating to chemotherapeutic agents in cancer. It is published by Bentham Science Publishers and the editor-in-chief is Simone Carradori. The journal covers developments in "medicinal chemistry and rational drug design for the discovery of anti-cancer agents" and publishes original research reports and review papers.
Medicinal Chemistry Research is a peer-reviewed scientific journal of medicinal chemistry emphasizing the structure-activity relationships of biologically active compounds. It was founded in 1991 by Alfred Burger, who also founded the Journal of Medicinal Chemistry. The journal is currently edited by Longqin Hu.
Jonathan Baell is trained as an Australian medicinal chemist and is currently executive director, early leads chemistry at Lyterian Therapeutics in San Francisco. Prior to this, he was a research professor in medicinal chemistry at the Monash Institute of Pharmaceutical Sciences (MIPS), the director of the Australian Translational Medicinal Chemistry Facility and a Chief Investigator at the ARC Centre for Fragment-Based Design. He was President of the International Chemical Biology Society 2018-2021 and is currently chair of the board. His research focuses on the early stages of drug discovery, including high-throughput screening (HTS) library design, hit-to-lead and lead optimization for the treatment of a variety of diseases, such as malaria and neglected diseases.
Sally-Ann Poulsen is an Australian chemical biologist who is a Professor and Director at Griffith University. Her research considers medicinal chemistry and drug discovery. She is Chair of the Royal Australian Chemical Institute Medicinal Chemistry and Chemical Biology Division.
